ASCO23
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ASCO23
Feb 14, 2024, 18:02 |
Blog
Mark Lewis: Dr. Andrew Ko’s observation at ASCO23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX!
Mark Lewis shared on X: “Seems relevant to resurface Dr. Andrew Ko’s observation at ASCO23…
Dec 17, 2023, 03:29 |
Blog
Advancing the Battle Against Platinum-Resistant Ovarian Cancer: Promising Strategies from 2023 ASCO & ESMO Meetings
The 2023 ASCO and ESMO meetings provided novel insights for treating platinum-resistant ovarian cancer, a…
Aug 16, 2023, 19:31 |
Societies
Mark your calendars for our FIRST live lung cancer journal club discussing updated results from the ADAURA trial - LungCancerRx
Quoting a post from Twitter user "LungCancerRx": "Exciting News! Mark your calendars for our FIRST…
Jul 18, 2023, 20:06 |
Blog
I argue that crossover should not be “allowed”- they should either be “mandated” or “prohibited” - Bishal Gyawali
Hot off the press in NatureRevClinOncol! Using examples from trials presented at ASCO23, in this…
Jun 22, 2023, 19:15 |
Positive
We are at a pivotal time for treatment innovations in hematological malignancies - Anas Younes
We are at a pivotal time for treatment innovations in hematological malignancies, and our data…
Jun 19, 2023, 18:18 |
Career
I rejoined (best!) ASCO International Affairs Committee in capacity as Chair-Elect - Herbert Loong
As ASCO23 ends & we eagerly look forward to ASCO24, I am pleased to announce…
Jun 12, 2023, 04:02 |
Blog
I closed my ASCO23 with 65507+ steps- Abdelali (Ali) MAJDI
I closed my ASCO23 with 65507+ steps Every step opened new opportunities to learn, connect, and…
Jun 10, 2023, 11:59 |
Blog
An Unforgettable Journey: Reflections on ASCO23 Annual Meeting - Matteo Lambertini
Time to go home after an exciting #ASCO23 annual meeting…I have to admit that when I entered…
Jun 10, 2023, 02:53 |
Blog
Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino
Consistent with the PACE trial, the PALMIRA randomized phase 2 trial showed no benefit in…
Jun 8, 2023, 18:38 |
Blog
I'm pleased to share three papers in Cancer Discovery- Elizabeth McKenna
I'm pleased to share three papers in #CancerDiscovery that were published simultaneously with posters/presentations at #ASCO23: From the…
1
2
All:
13
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube